Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial
Abstract Background Most opioid use disorder (OUD) treatment guidelines target community medical settings, and the subsequent recommendations were established to prioritize safety and reduce diversion prior to the fentanyl era. For people with OUD who use unregulated fentanyl, slow induction onto op...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-07-01
|
| シリーズ: | Addiction Science & Clinical Practice |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13722-025-00586-7 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
